Nadeem, O., Redd, R. A., Barth, P. M., Bayliss, T. J., Laubach, J. P., Bianchi, G., Mo, C. C., Reagan, J. L., Midha, S., Sperling, A. S., Liu, Y., Hartley-Brown, M. A., Chuma, M. P., Nicholson, T., Benjamin, E. J., Distaso, A., Regan, E., Hof, A. M. V., Dahill, A. J., Goldbaum, R., Mohammadi, K., Lewis, A., Poda, R., Munshi, N. C., Anderson, K. C., Ghobrial, I. M. and Richardson, P. G. (2020) “A phase I/II study of twice-weekly ixazomib plus pomalidomide and dexamethasone in relapsed and refractory multiple myeloma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300897.